Introduction
There have been sporadic reports dating back to 1934 of liver disease occurring in patients with scleroderma but the association occurs rarely. Thus D 'Angelo et al. (1969) found more instances of cirrhosis in fifty-eight control patients than in fiftyeight patients with systemic scleroderma, while Bartholomew et al. (1964) found only eight examples of chronic liver disease in 727 cases of scleroderma and concluded that there was no relationship between the two diseases. In 1958, Calvert et al. described two cases of scleroderma with portal hypertension who bled from oesophageal varices; in the first case, liver biopsy was not performed and in the Correspondence: Dr T. W. Warnes, Metabolic Ward, University College Hospital, Gower Street, London WCI 6AU.
second it showed only patchy fibrotic changes. In 1970, Reynolds et al. and Murray-Lyon et al. independently described the association of primary biliary cirrhosis with scleroderma. All the eight patients described by these workers had evidence of florid liver disease. In this paper we describe a case of CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia) who had neither symptoms nor signs of liver disease. Elevation of plasma alkaline phosphatase led to further investigations. On fractionation, the isoenzyme was shown to be of hepatic origin whilst the presence of antimitochondrial, antinuclear and smooth muscle antibodies in the serum suggested an associated autoimmune liver disease, which was confirmed by the histological findings on liver biopsy. We shall discuss this in relation to the recent observations of Fox, Scheuer and Sherlock (1973) Investigations. Radiological examination of both hands showed calcinosis circumscripta together with some tapering of the tips of the fingers and some calcinosis in the left wrist joint. Barium swallow showed a slightly dilated oesophagus which did not empty completely when the patient was supine; the motility was also diminished. Barium follow-up showed that the calibre of the proximal small bowel was at the upper limit of normal. Tests of pulmonary function were normal. The ECG showed a Q wave in leads III and aVF consistent with an old inferior myocardial infarct. Plasma urea and creatinine were normal as was the creatinine clearance. Haematology was normal. Tests of liver function showed a plasma bilirubin of 0 9 mg/100 ml; plasma alkaline phosphatase 63 KA units/100 ml; plasma glutamic oxaloacetic transaminase 23 iu/l (normal up to 14 iu/l), plasma glutamic pyruvic transaminase 23 iu/l (normal up to 10 iu/l), albumin 3 9 g/100 ml and globulin 3 8 g/100 ml. Electrophoresis showed moderate elevation of the gamma-globulin. The prothrombin index was normal. Plasma BSP test showed 23%/ retention at 45 min (normal less than 5%/). Separation of the isoenzymes of alkaline phosphatase by electrophoresis on polyacrylamide gel slabs (Anson and Rowe, 1970) showed that the elevated alkaline phosphatase was of hepatic origin (Fig. 1) . Serum IgG was 1880 mg/100 ml, IgM 720 mg/100 ml and IgA 330 mg/100 ml. The serum cholesterol, triglycerides and lipoprotein pattern were all normal. The immunofluorescent technique for antinuclear factor was positive. Antinuclear antibodies were present in a titre exceeding 1/160, smooth muscle antibodies were present at a dilution of 1 in 10 by immunofluorescence and antimitochondrial antibodies were present by immunofluorescence but gave a negative complement fixation titre. Rose Waaler test and rheumatoid slide latex tests were negative.
A needle biopsy (Figs 2 and 3) showed slight cholestasis and inflammatory cell infiltration about the portal system with bile ductule proliferation and reticulin increase which extended into lobules, disrupting the lobular pattern with isolation of groups of liver cells and possibly nodular regeneration. No definite liver cell necrosis was seen. No granulomata were observed. The histological appearances were those of autoimmune liver disease and were thought to be rather more compatible with active chronic hepatitis progressing to cirrhosis than with primary biliary cirrhosis.
Because of the subcutaneous calcification she was started on long-term treatment with probenecid up to 2 g daily as described by Dent and Stamp (1972) . She was not given any treatment for the liver disease.
Discussion
The CRST syndrome (Winterbauer, 1964 ) is a well recognized variant of scleroderma, which frequently runs a benign course. Although liver disease is thought to be rare in scleroderma, its association with primary biliary cirrhosis has been recently described. The two patients described by Murray-Lyon et al. (1970) presented with hepatosplenomegaly and one had features of CRST syndrome. All the six cases in the series of Reynolds et al. (1971) presented with pruritus and jaundice; three had hepatomegaly and splenomegaly. In both reports an elevated alkaline phosphatase and positive serum antimitochondrial antibody tests were constant features.
In the original description of primary biliary cirrhosis (Addison and Gull, 1851) the classical features were pruritus, jaundice, xanthomas, xanthelasmas, hepatosplenomegaly and skin pigmentation. Sherlock (1959) reported that 20%4 of the patients may not be jaundiced at the time of first diagnosis. Doniach and Walker (1969) have proposed a unified concept of autoimmune liver disease in which primary biliary cirrhosis, chronic active hepatitis and cryptogenic cirrhosis form a spectrum of one disease and may be aetiologically related.
Walker, Doniach and Doniach (1970) on screening a large number of hospital patients for antimitochondrial antibodies, detected thirty-five patients with subclinical liver disease and found minor histological changes in eight who were biopsied. Recently four asymptomatic patients with primary biliary cirrhosis have been reported (Fox et al., 1973) . All these patients had elevated alkaline phosphatase levels and antimitochondrial antibodies in the serum together with compatible histological findings on liver biopsy. This latter report highlights the problem of defining the prognosis in primary biliary cirrhosis since the diagnosis can now be made during the asymptomatic or subclinical phase.
The histological findings on liver biopsy may not be diagnostic (Scheuer, 1967) for it is often difficult to distinguish chronic active hepatitis from primary biliary cirrhosis in the early stages. Similarly, the end stages of the condition may be indistinguishable from the end stage of cirrhosis due to other causes (Mackay and Wood, 1962) . In the present patient, the same difficulty arose because the specimen on liver biopsy did not contain any medium sized bile ducts or granulomata. However, the presence of ANF, smooth muscle antibodies and antimitochondrial antibodies points to the existence of an autoimmune process in the liver.
Whilst treatment of chronic active hepatitis has been shown to improve the prognosis (British Medical Journal, 1973) there is no evidence for the efficacy of immuno-suppressive therapy in established primary biliary cirrhosis. Similarly, there is no evidence about the value of treatment in asymptomatic autoimmune liver disease and, therefore, we did not consider that therapy with steroids or azathioprine was indicated in this patient.
The true incidence of autoimmune liver disease in scleroderma is unknown and the present report clearly underlines that it may be quite asymptomatic. We suggest that routine measurement of the serum alkaline phosphatase in all patients with scleroderma is indicated as a simple screening procedure which would enable the true incidence of autoimmune liver disease in scleroderma to be established.
